RESUMO
BACKGROUND: Death due to prescription opioid exposure has increased dramatically in North America. Currently, there is a lack of literature detailing potentially lethal doses as well as postmortem tissue analysis concentrations from prescription opioid fatalities in children. We report a pediatric hydromorphone fatality with postmortem peripheral blood, central blood, liver, and gastric concentrations. CASE REPORT: A 3-year-old male was found unresponsive on a couch. Emergency services were contacted and responders found him pulseless, apneic, and asystolic. Resuscitative measures were unsuccessful and he was pronounced dead at a local hospital soon after arrival. Postmortem investigations revealed that two hydromorphone tablets (2 mg each) were missing. There was no demonstrable natural disease or traumatic injury to which to attribute his death upon autopsy; while postmortem concentrations of hydromorphone were confirmed and quantitated in peripheral blood at 0.03 mg/L, central blood 0.06 mg/L, and liver 0.10 mg/kg. CONCLUSION: Given the paucity of reported pediatric opioid-related fatalities, we describe a hydromorphonep-related death in a child, which includes postmortem hydromorphone concentrations.
Assuntos
Acidentes , Analgésicos Opioides/intoxicação , Hidromorfona/intoxicação , Analgésicos Opioides/farmacocinética , Autopsia , Pré-Escolar , Evolução Fatal , Humanos , Hidromorfona/farmacocinética , Masculino , Distribuição TecidualRESUMO
A 30-year-old man reportedly ingested pills and used illicit drugs with another person. They both fell asleep that night and the following afternoon the other person found him dead. There were used hypodermic needles and a metal spoon with dark tarry substance at the death scene, and two recent puncture sites were found on his body. It was uncertain if he had a history of illicit drug use. Postmortem blood initially screened borderline positive for methamphetamine by ELISA. An alkaline drug screen-detected ethylone which was subsequently confirmed and quantified by a specific GC-MS SIM analysis following solid-phase extraction. Concentrations were determined in the peripheral blood (0.39 mg/L), central blood (0.38 mg/L), liver (1.4 mg/kg), vitreous (0.58 mg/L), urine (20 mg/L) and gastric contents (12 mg). Other compounds detected in peripheral blood were morphine (0.05 mg/L), alprazolam (<0.05 mg/L), delta-9-THC (<1 ng/mL), delta-9-carboxy-THC (3.6 ng/mL) and naproxen (<5 mg/L). A urine screen (GC-MS) also confirmed 6-monoacetylmorphine, codeine and sildenafil. The cause of death was certified due to mixed ethylone, heroin and alprazolam intoxication. The manner of death was certified as accident.
Assuntos
Acetona/análogos & derivados , Overdose de Drogas/diagnóstico , Etilaminas/intoxicação , Drogas Ilícitas/intoxicação , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Acidentes , Acetona/análise , Acetona/intoxicação , Adulto , Alprazolam/análise , Autopsia , Causas de Morte , Overdose de Drogas/metabolismo , Ensaio de Imunoadsorção Enzimática , Etilaminas/análise , Evolução Fatal , Toxicologia Forense/métodos , Cromatografia Gasosa-Espectrometria de Massas , Heroína/análise , Humanos , Drogas Ilícitas/análise , Masculino , Valor Preditivo dos Testes , Extração em Fase Sólida , Detecção do Abuso de Substâncias/métodos , Transtornos Relacionados ao Uso de Substâncias/metabolismoRESUMO
Toxicological investigations were performed on an intracerebral hematoma, antemortem blood, and postmortem blood of an individual who was found unresponsive in his home. The hematoma was found to have ethanol at a concentration of 0.05% (w/v), and benzoylecgonine (a cocaine metabolite) was also confirmed at a concentration of 0.43 mg/L by specific analysis using gas chromatography/mass spectrometry (GC/MS). These results enabled the pathologist to record the cause of death as intracerebral hemorrhage due to acute cocaine intoxication.
Assuntos
Hemorragia Cerebral/induzido quimicamente , Cocaína/análogos & derivados , Cocaína/efeitos adversos , Inibidores da Captação de Dopamina/efeitos adversos , Hematoma/induzido quimicamente , Detecção do Abuso de Substâncias/métodos , Depressores do Sistema Nervoso Central/efeitos adversos , Depressores do Sistema Nervoso Central/análise , Cocaína/análise , Inibidores da Captação de Dopamina/análise , Etanol/efeitos adversos , Etanol/análise , Medicina Legal/métodos , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Masculino , Pessoa de Meia-Idade , RadioimunoensaioRESUMO
Carisoprodol is a therapeutic and occasionally abused centrally acting muscle relaxant. We compare central blood and liver concentrations of carisoprodol and the metabolite meprobamate to concentrations in peripheral blood in 11 medical examiner cases. Specimens were initially screened for alcohol and simple volatiles by gas chromatography (GC)-flame ionization detection headspace analysis, enzyme-linked immunosorbent array for drugs of abuse, and therapeutic drugs by GC-mass spectrometry (MS). Carisoprodol, when detected by the therapeutic drug screen, was confirmed and quantified by a specific GC-MS procedure. The results suggest that when ingested with other medications, carisoprodol may be a contributing factor in death, even when present at therapeutic concentrations. Considering the cases studied, together with previously published therapeutic and fatal concentrations, blood carisoprodol concentrations greater than 15 mg/L and liver concentrations greater than 50 mg/kg may be considered excessive and potentially fatal. Carisoprodol central blood to peripheral blood ratios averaged 1.31 + 0.33 (mean ± standard deviation), and liver to peripheral blood, 2.83 ± 1.51. Meprobamate central blood to peripheral blood ratios averaged 0.92 ± 0.22, and liver to peripheral blood, 1.25 ± 0.69. The low liver to peripheral blood ratio (less than 5), taken together with the low central blood to peripheral blood ratio, is an indicator that both carisoprodol and meprobamate lack the potential to exhibit postmortem redistribution.
Assuntos
Carisoprodol/intoxicação , Meprobamato/intoxicação , Relaxantes Musculares Centrais/intoxicação , Detecção do Abuso de Substâncias/métodos , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Carisoprodol/sangue , Carisoprodol/farmacocinética , Diagnóstico , Toxicologia Forense/métodos , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Fígado/metabolismo , Meprobamato/sangue , Meprobamato/farmacocinética , Relaxantes Musculares Centrais/sangue , Relaxantes Musculares Centrais/farmacocinética , Mudanças Depois da Morte , Transtornos Relacionados ao Uso de Substâncias/sangue , Suicídio , Distribuição TecidualRESUMO
There has been an increased awareness of illicit opiate abusers using the narcotic oxymorphone (Opana) by inhalation. Many laboratory screening techniques currently in use cannot detect oxymorphone in blood or urine. Consequently, biological specimens containing low to moderate concentrations of oxymorphone will likely go undetected. The circumstances, pathology findings, and toxicology results of two fatalities involving oxymorphone are presented. An opiate confirmation gas chromatography-mass spectrometry (GC-MS) procedure, described in detail was able to detected, confirm, and quantify oxymorphone in both subjects. The blood concentrations were 0.05 mg/L (50 microg/L) and 0.12 mg/L (120 microg/L).